AGP Picks
View all

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on September 10, 2026

Corporate & Event Planners Shift Toward Micro-Retreats in Urban Neighborhood Hubs
VEW Media Marks 25 Years of Building Visibility for Companies Across Industries and Around the World
Psychologist on Mensa's Gifted Youth Committee Publishes Framework for Identifying Twice-Exceptional Learners
Kadant Declares Cash Dividend
Merlin Demonstrates Autonomous Flight Capabilities at Texas Department of Transportation Project NEXUS eIPP Kickoff Event
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
Smartcat launches SCORM Studio, translating course libraries without touching a source file
Worden Marine Defines the Future of Sustainable Marine Transportation
Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
Solo.io Extends Agentic Governance to Any Environment with Solo Enterprise for agentgateway
Bullhorn named 2027 Salesforce 'Partner of the Year' award winner
Workable Adds AI Cost Transparency to Its AI-Powered ATS, Showing Enterprises Exactly What Each Hire Costs in Agent Credits
Lumafield Unveils Saturn Large-Format Industrial X-ray CT Scanner to Inspect Complex Assemblies and Dense Materials
Interra Health Adds Support for New GLP-1 Bridge Program, Helping Seniors on Medicare Access Weight-Loss Medications
Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company
CCC to Present Exclusive First Look at the 2026 Copyrighted Content Usage Trends Report During a September LinkedIn Live Event
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.